rs2290981

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_130810.4(DNAAF4):​c.406-329C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0501 in 151,792 control chromosomes in the GnomAD database, including 266 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.050 ( 266 hom., cov: 32)

Consequence

DNAAF4
NM_130810.4 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.158

Publications

3 publications found
Variant links:
Genes affected
DNAAF4 (HGNC:21493): (dynein axonemal assembly factor 4) This gene encodes a tetratricopeptide repeat domain-containing protein. The encoded protein interacts with estrogen receptors and the heat shock proteins, Hsp70 and Hsp90. An homologous protein in rat has been shown to function in neuronal migration in the developing neocortex. A chromosomal translocation involving this gene is associated with a susceptibility to developmental dyslexia. Mutations in this gene are associated with deficits in reading and spelling. Alternative splicing results in multiple transcript variants. Read-through transcription also exists between this gene and the downstream cell cycle progression 1 (CCPG1) gene. [provided by RefSeq, Mar 2011]
DNAAF4-CCPG1 (HGNC:43019): (DNAAF4-CCPG1 readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring dyslexia susceptibility 1 candidate 1 (DYX1C1) and cell cycle progression 1 (CCPG1) genes on chromosome 15. The read-through transcript is a candidate for nonsense-mediated mRNA decay (NMD), and is thus unlikely to produce a protein product. [provided by RefSeq, Mar 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BP6
Variant 15-55467490-G-A is Benign according to our data. Variant chr15-55467490-G-A is described in ClinVar as Benign. ClinVar VariationId is 1267505.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.138 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_130810.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNAAF4
NM_130810.4
MANE Select
c.406-329C>T
intron
N/ANP_570722.2Q8WXU2-1
DNAAF4
NM_001033560.2
c.406-329C>T
intron
N/ANP_001028732.1Q8WXU2-2
DNAAF4
NM_001033559.3
c.406-329C>T
intron
N/ANP_001028731.1Q8WXU2-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNAAF4
ENST00000321149.7
TSL:1 MANE Select
c.406-329C>T
intron
N/AENSP00000323275.3Q8WXU2-1
DNAAF4
ENST00000448430.6
TSL:1
c.406-329C>T
intron
N/AENSP00000403412.2Q8WXU2-2
DNAAF4
ENST00000457155.6
TSL:1
c.406-329C>T
intron
N/AENSP00000402640.2Q8WXU2-3

Frequencies

GnomAD3 genomes
AF:
0.0501
AC:
7605
AN:
151674
Hom.:
265
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0166
Gnomad AMI
AF:
0.0549
Gnomad AMR
AF:
0.0484
Gnomad ASJ
AF:
0.0641
Gnomad EAS
AF:
0.147
Gnomad SAS
AF:
0.141
Gnomad FIN
AF:
0.0341
Gnomad MID
AF:
0.0791
Gnomad NFE
AF:
0.0587
Gnomad OTH
AF:
0.0504
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0501
AC:
7600
AN:
151792
Hom.:
266
Cov.:
32
AF XY:
0.0501
AC XY:
3717
AN XY:
74172
show subpopulations
African (AFR)
AF:
0.0165
AC:
684
AN:
41434
American (AMR)
AF:
0.0482
AC:
732
AN:
15194
Ashkenazi Jewish (ASJ)
AF:
0.0641
AC:
222
AN:
3466
East Asian (EAS)
AF:
0.147
AC:
756
AN:
5138
South Asian (SAS)
AF:
0.141
AC:
680
AN:
4808
European-Finnish (FIN)
AF:
0.0341
AC:
358
AN:
10512
Middle Eastern (MID)
AF:
0.0714
AC:
21
AN:
294
European-Non Finnish (NFE)
AF:
0.0587
AC:
3987
AN:
67930
Other (OTH)
AF:
0.0522
AC:
110
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
366
732
1099
1465
1831
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
94
188
282
376
470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0481
Hom.:
36
Bravo
AF:
0.0478
Asia WGS
AF:
0.118
AC:
410
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
0.34
DANN
Benign
0.18
PhyloP100
-0.16
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2290981; hg19: chr15-55759688; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.